Results 191 to 200 of about 943,185 (296)
Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim+18 more
wiley +1 more source
An update on diagnosis and treatments of childhood interstitial lung diseases. [PDF]
Marczak H+14 more
europepmc +1 more source
STUDIES OF RESPIRATORY PHYSIOLOGY IN CHILDREN. VI. LUNG DIFFUSING CAPACITY, DIFFUSING CAPACITY OF THE PULMONARY MEMBRANE AND PULMONARY CAPILLARY BLOOD VOLUME IN CONGENITAL HEART DISEASE* [PDF]
Giovanni Bucci, Charles D. Cook
openalex +1 more source
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla+13 more
wiley +1 more source
Incidence and survival of interstitial lung diseases in the UK in 2010-2019. [PDF]
Gonnelli F+10 more
europepmc +1 more source
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999‐2021. RA‐ILD patients were
Bryant R. England+9 more
wiley +1 more source
LGD_Net: Capsule network with extreme learning machine for classification of lung diseases using CT scans. [PDF]
Khan AH, Li J, Asghar MN, Iqbal S.
europepmc +1 more source
The Normal Pulmonary Angiogram and Some Changes Seen in Chronic Nonspecific Lung Disease [PDF]
G. D. Scarrow
openalex +1 more source